BriaCell Therapeutics Corp.
Balance Sheet
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $9.9M | $10.5M | $862.1K | $21.3M | $41.0M | $57.3M | $21.2K | $157.0K |
| Accounts Receivable | — | — | — | $18.9K | $24.1K | $12.6K | $22.5K | $2.8K |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $22.0M | $19.9M | $3.7M | $26.9M | $42.3M | $57.8M | $261.5K | $168.5K |
| Property, Plant & Equipment | $319.8K | $296.8K | $388.2K | $2.5K | $2.5K | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $169.3K | $184.5K | $199.8K | $215.1K | $230.3K | $245.6K | — | — |
| Total Assets | $23.6M | $21.6M | $5.9M | $27.2M | $42.6M | $58.0M | $522.3K | $444.7K |
| Liabilities | ||||||||
| Accounts Payable | $7.0M | $3.3M | $7.2M | $1.1M | $463.3K | $214.1K | $3.7M | $810.8K |
| Total Current Liabilities | $8.0M | $4.0M | $7.5M | $1.8M | $941.1K | $556.8K | $4.0M | $1.1M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $8.0M | $4.3M | $8.6M | $30.9M | $32.2M | $30.4M | $3.3M | $1.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-146.7M | $-111.8M | $-85.4M | $-80.7M | $-60.3M | $-29.1M | $-18.2M | $-14.7M |
| Total Stockholders' Equity | $15.6M | $17.3M | $-2.7M | $-3.8M | $10.3M | $27.7M | $-2.7M | $-688.7K |